Dec'04 | Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | $0.0 | $0.0 | $2,169.8K | $4,627.0K | $9,838.0K | $29.7M | $48.6M | $76.3M | $99.9M | $160.0M | $259.2M | $402.0M | $573.3M | $718.5M | $1,031.6M | $1,476.0M | $1,926.7M | $2,448.5M | $2,909.8M | $3,622.3M |
Discover the top 20 best undervalued stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Jan 2025.
As of today, DexCom, Inc.'s last 12-month Revenue is $3,954.0M, based on the financial report for Sep 30, 2024 (Q3 2024).
Over the last year, DexCom, Inc.'s Revenue growth was 16.2%. The average annual Revenue growth rates for DexCom, Inc. have been 25.0% over the past three years, 24.0% over the past five years.
Over the last year, DexCom, Inc.'s Revenue growth was 16.2%, which is higher than industry growth of 0.1%. It indicates that DexCom, Inc.'s Revenue growth is Good.